文献速递腹部技术与安全CT

双层光谱CT术前预测可切除胰腺导管腺癌淋巴结转移

The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography.
PubMed 文献 · Eur Radiol · 2024-10-24

回顾性纳入107例可切除胰腺导管腺癌患者,按7:3随机分为训练集与验证集,分析临床数据、CT形态学特征及双层光谱CT参数。静脉期碘浓度、细胞外容积和肿瘤大小是淋巴结转移的独立预测因子,列线图模型训练集AUC 0.877(95%CI 0.803-0.952)、验证集AUC 0.842(95%CI 0.707-0.977),均高于淋巴结形态学特征。

要点

  • 静脉期碘浓度、细胞外容积和肿瘤大小是可切除PDAC淋巴结转移的独立预测因子。
  • 列线图模型训练集AUC 0.877、验证集AUC 0.842,高于淋巴结形态学特征的0.570和0.583。
  • 双层光谱CT参数对可切除PDAC淋巴结转移有潜在预测价值。

核心结论

  • 双层光谱CT有潜力预测可切除胰腺导管腺癌患者的淋巴结转移,预测价值优于淋巴结形态学特征。

研究设计与样本

  • 回顾性研究,纳入107例可切除胰腺导管腺癌患者(44例有淋巴结转移、63例无淋巴结转移),按7:3随机分为训练集与验证集;术前2周内行双层光谱CT检查,分析临床数据、CT形态学特征及DLCT参数,采用单因素和多因素logistic分析筛选预测因子并构建模型,以ROC曲线评价预测效能。

诊断标准与关键数值

  • 静脉期碘浓度、细胞外容积和肿瘤大小为淋巴结转移的独立预测因子;列线图模型(包含两个DLCT参数和形态学特征)预测淋巴结转移的AUC在训练集为0.877(95%CI 0.803-0.952)、验证集为0.842(95%CI 0.707-0.977);淋巴结形态学特征AUC在训练集为0.570、验证集为0.583。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the value of dual-layer spectral computed tomography (DLCT) parameters derived from primary tumors in predicting lymph node metastasis (LNM) of resectable pancreatic ductal adenocarcinoma (PDAC).

MATERIALS AND METHODS: In this retrospective study, patients with resectable PDAC who underwent DLCT within 2-week intervals before surgery were enrolled and randomly divided into training and validation sets at a 7:3 ratio. The patients' clinical data, CT morphological features, and DLCT parameters were analyzed. Univariate and multivariate logistic analyses were used to identify the predictors and construct a predictive model, and receiver operator characteristic (ROC) curves were programmed to evaluate the predictive efficacy.

RESULTS: We enrolled 107 patients (44 patients with LNM and 63 patients without LNM). Among all variables, iodine concentration in the venous phase, extracellular volume, and tumor size were identified as independent predictors of LNM. The nomogram model, incorporating the two DLCT parameters and the morphological feature, achieved an area under the curve (AUC) of 0.877 (95% confidence interval [CI]: 0.803-0.952) and 0.842 (95% CI: 0.707-0.977) for predicting LNM in the training and validation sets, respectively. Furthermore, the AUC of the nomogram model was greater than that of morphological features of lymph nodes in the training (AUC = 0.877 vs. 0.570) and validation (AUC = 0.842 vs. 0.583) sets.

CONCLUSIONS: DLCT has the potential to predict LNM in patients with resectable PDAC and show a better predictive value than morphological features of lymph nodes.

KEY POINTS: Question Morphological features of lymph nodes are of limited value in detecting metastatic lymph nodes in pancreatic ductal adenocarcinoma (PDAC). Findings Dual-layer spectral computed tomography (DLCT) parameters and morphological features derived from PDAC lesions show good preoperatively predictive efficacy for lymph node metastasis. Clinical relevance The proposed DLCT-based nomogram model may serve as an effective and convenient tool for preoperatively predicting lymph node metastasis of resectable PDAC.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Xie T, Chen L, et al. The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography. Eur Radiol. 2024. PMID: 39448418. doi:10.1007/s00330-024-11143-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。